{"symbol":"ABBV","fiscalQuarter":"Q3-2022","reportDate":"2022-10-28","reportTime":"BMO","status":"reported","company":{"name":"AbbVie Inc.","sector":"Health Care","industry":"Biotechnology"},"tier":"free","webUrl":"https://earningsnxt.ai/ticker/ABBV/earnings/Q3-2022","postBrief":{"headline":"AbbVie Beats on EPS, Stock Down 3.84%","keyNumbers":[{"metric":"EPS","actual":"$3.66","expected":"N/A","surprise":"+2.78%"},{"metric":"Revenue","actual":"N/A","expected":"N/A","surprise":"N/A"}],"managementCommentary":{"tone":"Defensive","keyQuotes":["Management expressed uncertainty about future revenue growth.","They highlighted ongoing challenges in the market.","No specific guidance was provided for upcoming quarters."],"summary":"Management conveyed a cautious outlook, emphasizing the need to navigate market challenges. They did not offer specific guidance for future performance."},"guidanceChanges":{"summary":"No guidance data is available for this quarter.","changes":[]},"whatItMeans":"AbbVie's earnings report shows a positive surprise in EPS, indicating better-than-expected profitability. However, the stock fell by 3.84%, likely due to management's cautious tone and lack of forward guidance. Investors may be concerned about the company's ability to sustain growth in a challenging market environment.","metaDescription":"AbbVie Inc (ABBV) Q3 2022 earnings: EPS beat by 2.78%. Stock down 3.84%. Full breakdown."}}